Skip to main content
main-content

Tipp

Weitere Artikel dieser Ausgabe durch Wischen aufrufen

Erschienen in: European Surgery 4/2016

01.08.2016 | Review

Current strategies for preoperative conditioning of the liver to expand criteria for resectability of hepatic metastases

verfasst von: H. M. Hau, H. -M. Tautenhahn, M. Schmelzle, H. M. Morgul, M. Moche, M. Bartels, FACS Prof. Dr. med. D. Uhlmann

Erschienen in: European Surgery | Ausgabe 4/2016

Einloggen, um Zugang zu erhalten
share
TEILEN

Summary

Background

Colorectal cancer (CRC) is among the most commonly diagnosed cancers, and the liver is its most frequent metastatic site. Colorectal liver metastases (CLM) are synchronous in 15–25 % of the CRC patients and metachronous in 20–25 %. In recent decades, 5-year-overall survival following curative liver resection of CLM has increased to 35–58 %. This improvement owes largely to advances in CLM multimodality treatment.

Methods

In recent years, the CLM resectability criteria have also shifted, following several encouraging studies reporting the possibility of R0 resection for all tumors while preserving a sufficient volume of residual liver. In this context, multimodal approaches including portal vein embolization (PVE), associating liver partition with portal vein ligation for staged hepatectomy (ALPPS) and two-stage hepatectomy after neoadjuvant chemotherapy were developed to induce hypertrophy of the future liver remnant (FLR) to fulfill minimal liver volume requirements. Liver function tests and scores could be a helpful tool in patient selection and prediction limit of the hepatic parenchymal reserve.

Results

Generally, at least 20 % of the total liver volume should be preserved in the case of a healthy liver, whereas at least 30–60 % should be preserved for livers impaired by chemotherapy-associated steatosis or hepatitis. Further use of ischemic or pharmacological preconditioning of FLR tissue such as stem cell transplantation could help to prepare the liver for extended resections and to avoid postoperative liver failure.

Conclusion

Because of shifting CLM resectability criteria and encouraging survival rates following curative resection in the context of multimodality treatment, extended liver surgery for CLM is increasing. To condition the liver for extensive surgery and to ensure adequate postoperative liver function, several approaches were developed and routinely practiced in clinical centers.
Literatur
3.
Zurück zum Zitat Adam R, De Gramont A, Figueras J, Guthrie A, Kokudo N, Kunstlinger F, Loyer E, Poston G, Rougier P, Rubbia-Brandt L, Sobrero A, Tabernero J, Teh C, Van Cutsem E. The oncosurgery approach to managing liver metastases from colorectal cancer: a multidisciplinary international consensus. Oncologist. 2012;17:1225–39. doi: 10.​1634/​theoncologist.​2012-0121. CrossRefPubMedPubMedCentral Adam R, De Gramont A, Figueras J, Guthrie A, Kokudo N, Kunstlinger F, Loyer E, Poston G, Rougier P, Rubbia-Brandt L, Sobrero A, Tabernero J, Teh C, Van Cutsem E. The oncosurgery approach to managing liver metastases from colorectal cancer: a multidisciplinary international consensus. Oncologist. 2012;17:1225–39. doi: 10.​1634/​theoncologist.​2012-0121. CrossRefPubMedPubMedCentral
5.
Zurück zum Zitat Nordlinger B, Van Cutsem E, Rougier P, Köhne C-H, Ychou M, Sobrero A, Adam R, Arvidsson D, Carrato A, Georgoulias V, Giuliante F, Glimelius B, Golling M, Gruenberger T, Tabernero J, Wasan H, Poston G. Does chemotherapy prior to liver resection increase the potential for cure in patients with metastatic colorectal cancer? A report from the European Colorectal Metastases Treatment Group. Eur J Cancer. 2007;43:2037–45. doi: 10.​1016/​j.​ejca.​2007.​07.​017. CrossRefPubMed Nordlinger B, Van Cutsem E, Rougier P, Köhne C-H, Ychou M, Sobrero A, Adam R, Arvidsson D, Carrato A, Georgoulias V, Giuliante F, Glimelius B, Golling M, Gruenberger T, Tabernero J, Wasan H, Poston G. Does chemotherapy prior to liver resection increase the potential for cure in patients with metastatic colorectal cancer? A report from the European Colorectal Metastases Treatment Group. Eur J Cancer. 2007;43:2037–45. doi: 10.​1016/​j.​ejca.​2007.​07.​017. CrossRefPubMed
6.
Zurück zum Zitat Ardito F, Vellone M, Barbaro B, Grande G, Clemente G, Giovannini I, Federico B, Bonomo L, Nuzzo G, Giuliante F. Right and extended-right hepatectomies for unilobar colorectal metastases: impact of portal vein embolization on long-term outcome and liver recurrence. Surgery. 2013;153:801–10. doi: 10.​1016/​j.​surg.​2013.​02.​001. CrossRefPubMed Ardito F, Vellone M, Barbaro B, Grande G, Clemente G, Giovannini I, Federico B, Bonomo L, Nuzzo G, Giuliante F. Right and extended-right hepatectomies for unilobar colorectal metastases: impact of portal vein embolization on long-term outcome and liver recurrence. Surgery. 2013;153:801–10. doi: 10.​1016/​j.​surg.​2013.​02.​001. CrossRefPubMed
9.
Zurück zum Zitat Rauchfuss F, Scheuerlein H, Lopatta E, Dittmar Y, Schüle S, Settmacher U. Portal vein embolisation prior to extended liver resection—current and future aspects. Zentralbl Chir. 2013;138:442–8. doi: 10.​1055/​s-0032-1328350. CrossRefPubMed Rauchfuss F, Scheuerlein H, Lopatta E, Dittmar Y, Schüle S, Settmacher U. Portal vein embolisation prior to extended liver resection—current and future aspects. Zentralbl Chir. 2013;138:442–8. doi: 10.​1055/​s-0032-1328350. CrossRefPubMed
10.
Zurück zum Zitat Pawlik TM, Scoggins CR, Zorzi D, Abdalla EK, Andres A, Eng C, Curley SA, Loyer EM, Muratore A, Mentha G, Capussotti L, Vauthey J-N. Effect of surgical margin status on survival and site of recurrence after hepatic resection for colorectal metastases. Ann Surg. 2005;241:715–244. CrossRefPubMedPubMedCentral Pawlik TM, Scoggins CR, Zorzi D, Abdalla EK, Andres A, Eng C, Curley SA, Loyer EM, Muratore A, Mentha G, Capussotti L, Vauthey J-N. Effect of surgical margin status on survival and site of recurrence after hepatic resection for colorectal metastases. Ann Surg. 2005;241:715–244. CrossRefPubMedPubMedCentral
13.
Zurück zum Zitat Clavien PA, Yadav S, Sindram D, Bentley RC. Protective effects of ischemic preconditioning for liver resection performed under inflow occlusion in humans. Ann Surg. 2000;232:155–62. CrossRefPubMedPubMedCentral Clavien PA, Yadav S, Sindram D, Bentley RC. Protective effects of ischemic preconditioning for liver resection performed under inflow occlusion in humans. Ann Surg. 2000;232:155–62. CrossRefPubMedPubMedCentral
17.
Zurück zum Zitat Vauthey JN, Chaoui A, Do KA, Bilimoria MM, Fenstermacher MJ, Charnsangavej C, Hicks M, Alsfasser G, Lauwers G, Hawkins IF, Caridi J. Standardized measurement of the future liver remnant prior to extended liver resection: methodology and clinical associations. Surgery. 2000;127:512–9. doi: 10.​1067/​mys.​2000.​105294. CrossRefPubMed Vauthey JN, Chaoui A, Do KA, Bilimoria MM, Fenstermacher MJ, Charnsangavej C, Hicks M, Alsfasser G, Lauwers G, Hawkins IF, Caridi J. Standardized measurement of the future liver remnant prior to extended liver resection: methodology and clinical associations. Surgery. 2000;127:512–9. doi: 10.​1067/​mys.​2000.​105294. CrossRefPubMed
18.
Zurück zum Zitat Azoulay D, Castaing D, Smail A, Adam R, Cailliez V, Laurent A, Lemoine A, Bismuth H. Resection of nonresectable liver metastases from colorectal cancer after percutaneous portal vein embolization. Ann Surg. 2000;231:480–6. CrossRefPubMedPubMedCentral Azoulay D, Castaing D, Smail A, Adam R, Cailliez V, Laurent A, Lemoine A, Bismuth H. Resection of nonresectable liver metastases from colorectal cancer after percutaneous portal vein embolization. Ann Surg. 2000;231:480–6. CrossRefPubMedPubMedCentral
19.
Zurück zum Zitat Shoup M, Gonen M, D’Angelica M, Jarnagin WR, DeMatteo RP, Schwartz LH, Tuorto S, Blumgart LH, Fong Y. Volumetric analysis predicts hepatic dysfunction in patients undergoing major liver resection. J Gastrointest Surg. 2003;7:325–30. CrossRefPubMed Shoup M, Gonen M, D’Angelica M, Jarnagin WR, DeMatteo RP, Schwartz LH, Tuorto S, Blumgart LH, Fong Y. Volumetric analysis predicts hepatic dysfunction in patients undergoing major liver resection. J Gastrointest Surg. 2003;7:325–30. CrossRefPubMed
20.
Zurück zum Zitat Kubota K, Makuuchi M, Kusaka K, Kobayashi T, Miki K, Hasegawa K, Harihara Y, Takayama T. Measurement of liver volume and hepatic functional reserve as a guide to decision-making in resectional surgery for hepatic tumors. Hepatology. 1997;26:1176–81. doi: 10.​1053/​jhep.​1997.​v26.​pm0009362359. PubMed Kubota K, Makuuchi M, Kusaka K, Kobayashi T, Miki K, Hasegawa K, Harihara Y, Takayama T. Measurement of liver volume and hepatic functional reserve as a guide to decision-making in resectional surgery for hepatic tumors. Hepatology. 1997;26:1176–81. doi: 10.​1053/​jhep.​1997.​v26.​pm0009362359. PubMed
21.
Zurück zum Zitat Heymsfield SB, Fulenwider T, Nordlinger B, Barlow R, Sones P, Kutner M. Accurate measurement of liver, kidney, and spleen volume and mass by computerized axial tomography. Ann Intern Med. 1979;90:185–7. CrossRefPubMed Heymsfield SB, Fulenwider T, Nordlinger B, Barlow R, Sones P, Kutner M. Accurate measurement of liver, kidney, and spleen volume and mass by computerized axial tomography. Ann Intern Med. 1979;90:185–7. CrossRefPubMed
23.
Zurück zum Zitat Robinson SM, Wilson CH, Burt AD, Manas DM, White SA. Chemotherapy-associated liver injury in patients with colorectal liver metastases: a systematic review and meta-analysis. Ann Surg Oncol;19:4287–99. doi: 10.​1245/​s10434-012-2438-8. Robinson SM, Wilson CH, Burt AD, Manas DM, White SA. Chemotherapy-associated liver injury in patients with colorectal liver metastases: a systematic review and meta-analysis. Ann Surg Oncol;19:4287–99. doi: 10.​1245/​s10434-012-2438-8.
24.
Zurück zum Zitat Rous P, Larimore LD. Relation of the portal blood to liver maintenance: a demonstration of liver atrophy conditional on compensation. J Exp Med. 1920;31:609–32. CrossRefPubMedPubMedCentral Rous P, Larimore LD. Relation of the portal blood to liver maintenance: a demonstration of liver atrophy conditional on compensation. J Exp Med. 1920;31:609–32. CrossRefPubMedPubMedCentral
25.
Zurück zum Zitat Kinoshita H, Sakai K, Hirohashi K, Igawa S, Yamasaki O, Kubo S. Preoperative portal vein embolization for hepatocellular carcinoma. World J Surg. 1986;10:803–8. CrossRefPubMed Kinoshita H, Sakai K, Hirohashi K, Igawa S, Yamasaki O, Kubo S. Preoperative portal vein embolization for hepatocellular carcinoma. World J Surg. 1986;10:803–8. CrossRefPubMed
27.
Zurück zum Zitat Makuuchi M, Thai BL, Takayasu K, Takayama T, Kosuge T, Gunvén P, Yamazaki S, Hasegawa H, Ozaki H. Preoperative portal embolization to increase safety of major hepatectomy for hilar bile duct carcinoma: a preliminary report. Surgery. 1990;107:521–7. PubMed Makuuchi M, Thai BL, Takayasu K, Takayama T, Kosuge T, Gunvén P, Yamazaki S, Hasegawa H, Ozaki H. Preoperative portal embolization to increase safety of major hepatectomy for hilar bile duct carcinoma: a preliminary report. Surgery. 1990;107:521–7. PubMed
28.
29.
Zurück zum Zitat Aussilhou B, Dokmak S, Faivre S, Paradis V, Vilgrain V, Belghiti J. Preoperative liver hypertrophy induced by portal flow occlusion before major hepatic resection for colorectal metastases can be impaired by bevacizumab. Ann Surg Oncol. 2009;16:1553–9. doi: 10.​1245/​s10434-009-0447-z. CrossRefPubMed Aussilhou B, Dokmak S, Faivre S, Paradis V, Vilgrain V, Belghiti J. Preoperative liver hypertrophy induced by portal flow occlusion before major hepatic resection for colorectal metastases can be impaired by bevacizumab. Ann Surg Oncol. 2009;16:1553–9. doi: 10.​1245/​s10434-009-0447-z. CrossRefPubMed
30.
Zurück zum Zitat Van Lienden KP, van den Esschert JW, de Graaf W, Bipat S, Lameris JS, van Gulik TM, van Delden OM. Portal vein embolization before liver resection: a systematic review. Cardiovasc Intervent Radiol. 2013;36:25–34. doi: 10.​1007/​s00270-012-0440-y. CrossRefPubMed Van Lienden KP, van den Esschert JW, de Graaf W, Bipat S, Lameris JS, van Gulik TM, van Delden OM. Portal vein embolization before liver resection: a systematic review. Cardiovasc Intervent Radiol. 2013;36:25–34. doi: 10.​1007/​s00270-012-0440-y. CrossRefPubMed
31.
32.
Zurück zum Zitat Geisel D, Malinowski M, Powerski M-J, Wüstefeld J, Heller V, Denecke T, Stockmann M, Gebauer B. Improved hypertrophy of future remnant liver after portal vein embolization with plugs, coils and particles. Cardiovasc Intervent Radiol. 2014;37:1251–8. doi: 10.​1007/​s00270-013-0810-0. CrossRefPubMed Geisel D, Malinowski M, Powerski M-J, Wüstefeld J, Heller V, Denecke T, Stockmann M, Gebauer B. Improved hypertrophy of future remnant liver after portal vein embolization with plugs, coils and particles. Cardiovasc Intervent Radiol. 2014;37:1251–8. doi: 10.​1007/​s00270-013-0810-0. CrossRefPubMed
33.
Zurück zum Zitat De Baere T, Teriitehau C, Deschamps F, Catherine L, Rao P, Hakime A, Auperin A, Goere D, Elias D, Hechelhammer L. Predictive factors for hypertrophy of the future remnant liver after selective portal vein embolization. Ann Surg Oncol. 2010;17:2081–9. doi: 10.​1245/​s10434-010-0979-2. CrossRefPubMed De Baere T, Teriitehau C, Deschamps F, Catherine L, Rao P, Hakime A, Auperin A, Goere D, Elias D, Hechelhammer L. Predictive factors for hypertrophy of the future remnant liver after selective portal vein embolization. Ann Surg Oncol. 2010;17:2081–9. doi: 10.​1245/​s10434-010-0979-2. CrossRefPubMed
35.
Zurück zum Zitat Ribero D, Abdalla EK, Madoff DC, Donadon M, Loyer EM, Vauthey J-N. Portal vein embolization before major hepatectomy and its effects on regeneration, resectability and outcome. Br J Surg. 2007;94:1386–94. doi: 10.​1002/​bjs.​5836. CrossRefPubMed Ribero D, Abdalla EK, Madoff DC, Donadon M, Loyer EM, Vauthey J-N. Portal vein embolization before major hepatectomy and its effects on regeneration, resectability and outcome. Br J Surg. 2007;94:1386–94. doi: 10.​1002/​bjs.​5836. CrossRefPubMed
39.
Zurück zum Zitat Simoneau E, Aljiffry M, Salman A, Abualhassan N, Cabrera T, Valenti D, El Baage A, Jamal M, Kavan P, Al-Abbad S, Chaudhury P, Hassanain M, Metrakos P. Portal vein embolization stimulates tumour growth in patients with colorectal cancer liver metastases. HPB (Oxford). 2012;14:461–8. doi: 10.​1111/​j.​1477-2574.​2012.​00476.​x. CrossRef Simoneau E, Aljiffry M, Salman A, Abualhassan N, Cabrera T, Valenti D, El Baage A, Jamal M, Kavan P, Al-Abbad S, Chaudhury P, Hassanain M, Metrakos P. Portal vein embolization stimulates tumour growth in patients with colorectal cancer liver metastases. HPB (Oxford). 2012;14:461–8. doi: 10.​1111/​j.​1477-2574.​2012.​00476.​x. CrossRef
40.
Zurück zum Zitat Pommier R, Ronot M, Cauchy F, Gaujoux S, Fuks D, Faivre S, Belghiti J, Vilgrain V. Colorectal liver metastases growth in the embolized and non-embolized liver after portal vein embolization: influence of initial response to induction chemotherapy. Ann Surg Oncol. 2014;21:3077–83. doi: 10.​1245/​s10434-014-3700-z. CrossRefPubMed Pommier R, Ronot M, Cauchy F, Gaujoux S, Fuks D, Faivre S, Belghiti J, Vilgrain V. Colorectal liver metastases growth in the embolized and non-embolized liver after portal vein embolization: influence of initial response to induction chemotherapy. Ann Surg Oncol. 2014;21:3077–83. doi: 10.​1245/​s10434-014-3700-z. CrossRefPubMed
42.
Zurück zum Zitat Fischer C, Melstrom LG, Arnaoutakis D, Jarnagin W, Brown K, D’Angelica M, Covey A, DeMatteo R, Allen P, Kingham TP, Tuorto S, Kemeny N, Fong Y. Chemotherapy after portal vein embolization to protect against tumor growth during liver hypertrophy before hepatectomy. JAMA Surg. 2013;148:1103–8. doi: 10.​1001/​jamasurg.​2013.​2126. CrossRefPubMed Fischer C, Melstrom LG, Arnaoutakis D, Jarnagin W, Brown K, D’Angelica M, Covey A, DeMatteo R, Allen P, Kingham TP, Tuorto S, Kemeny N, Fong Y. Chemotherapy after portal vein embolization to protect against tumor growth during liver hypertrophy before hepatectomy. JAMA Surg. 2013;148:1103–8. doi: 10.​1001/​jamasurg.​2013.​2126. CrossRefPubMed
43.
Zurück zum Zitat Van Gulik TM, van den Esschert JW, de Graaf W, van Lienden KP, Busch ORC, Heger M, van Delden OM, Laméris JS, Gouma DJ. Controversies in the use of portal vein embolization. Dig Surg. 2008;25:436–44. doi: 10.​1159/​000184735. CrossRefPubMed Van Gulik TM, van den Esschert JW, de Graaf W, van Lienden KP, Busch ORC, Heger M, van Delden OM, Laméris JS, Gouma DJ. Controversies in the use of portal vein embolization. Dig Surg. 2008;25:436–44. doi: 10.​1159/​000184735. CrossRefPubMed
44.
Zurück zum Zitat Knoefel WT, Gabor I, Rehders A, Alexander A, Krausch M, Schulte am Esch J, Fürst G, Topp SA. In situ liver transection with portal vein ligation for rapid growth of the future liver remnant in two-stage liver resection. Br J Surg. 2013;100:388–94. doi: 10.​1002/​bjs.​8955. CrossRefPubMed Knoefel WT, Gabor I, Rehders A, Alexander A, Krausch M, Schulte am Esch J, Fürst G, Topp SA. In situ liver transection with portal vein ligation for rapid growth of the future liver remnant in two-stage liver resection. Br J Surg. 2013;100:388–94. doi: 10.​1002/​bjs.​8955. CrossRefPubMed
45.
Zurück zum Zitat Covey AM, Brown KT, Jarnagin WR, Brody LA, Schwartz L, Tuorto S, Sofocleous CT, D’Angelica M, Getrajdman GI, DeMatteo R, Kemeny NE, Fong Y. Combined portal vein embolization and neoadjuvant chemotherapy as a treatment strategy for resectable hepatic colorectal metastases. Ann Surg. 2008;247:451–5. doi: 10.​1097/​SLA.​0b013e31815ed693​. CrossRefPubMed Covey AM, Brown KT, Jarnagin WR, Brody LA, Schwartz L, Tuorto S, Sofocleous CT, D’Angelica M, Getrajdman GI, DeMatteo R, Kemeny NE, Fong Y. Combined portal vein embolization and neoadjuvant chemotherapy as a treatment strategy for resectable hepatic colorectal metastases. Ann Surg. 2008;247:451–5. doi: 10.​1097/​SLA.​0b013e31815ed693​. CrossRefPubMed
50.
Zurück zum Zitat Adam R, Laurent A, Azoulay D, Castaing D, Bismuth H. Two-stage hepatectomy: a planned strategy to treat irresectable liver tumors. Ann Surg. 2000;232:777–85. CrossRefPubMedPubMedCentral Adam R, Laurent A, Azoulay D, Castaing D, Bismuth H. Two-stage hepatectomy: a planned strategy to treat irresectable liver tumors. Ann Surg. 2000;232:777–85. CrossRefPubMedPubMedCentral
51.
Zurück zum Zitat Narita M, Oussoultzoglou E, Jaeck D, Fuchschuber P, Rosso E, Pessaux P, Marzano E, Bachellier P. Two-stage hepatectomy for multiple bilobar colorectal liver metastases. Br J Surg. 2011;98:1463–75. doi: 10.​1002/​bjs.​7580. CrossRefPubMed Narita M, Oussoultzoglou E, Jaeck D, Fuchschuber P, Rosso E, Pessaux P, Marzano E, Bachellier P. Two-stage hepatectomy for multiple bilobar colorectal liver metastases. Br J Surg. 2011;98:1463–75. doi: 10.​1002/​bjs.​7580. CrossRefPubMed
52.
Zurück zum Zitat Brouquet A, Abdalla EK, Kopetz S, Garrett CR, Overman MJ, Eng C, Andreou A, Loyer EM, Madoff DC, Curley SA, Vauthey J-N. High survival rate after two-stage resection of advanced colorectal liver metastases: response-based selection and complete resection define outcome. J Clin Oncol. 2011;29:1083–90. doi: 10.​1200/​JCO.​2010.​32.​6132. CrossRefPubMedPubMedCentral Brouquet A, Abdalla EK, Kopetz S, Garrett CR, Overman MJ, Eng C, Andreou A, Loyer EM, Madoff DC, Curley SA, Vauthey J-N. High survival rate after two-stage resection of advanced colorectal liver metastases: response-based selection and complete resection define outcome. J Clin Oncol. 2011;29:1083–90. doi: 10.​1200/​JCO.​2010.​32.​6132. CrossRefPubMedPubMedCentral
54.
Zurück zum Zitat Schnitzbauer AA, Lang SA, Goessmann H, Nadalin S, Baumgart J, Farkas SA, Fichtner-Feigl S, Lorf T, Goralcyk A, Hörbelt R, Kroemer A, Loss M, Rümmele P, Scherer MN, Padberg W, Königsrainer A, Lang H, Obed A, Schlitt HJ. Right portal vein ligation combined with in situ splitting induces rapid left lateral liver lobe hypertrophy enabling 2-staged extended right hepatic resection in small-for-size settings. Ann Surg. 2012;255:405–14. doi: 10.​1097/​SLA.​0b013e31824856f5​. CrossRefPubMed Schnitzbauer AA, Lang SA, Goessmann H, Nadalin S, Baumgart J, Farkas SA, Fichtner-Feigl S, Lorf T, Goralcyk A, Hörbelt R, Kroemer A, Loss M, Rümmele P, Scherer MN, Padberg W, Königsrainer A, Lang H, Obed A, Schlitt HJ. Right portal vein ligation combined with in situ splitting induces rapid left lateral liver lobe hypertrophy enabling 2-staged extended right hepatic resection in small-for-size settings. Ann Surg. 2012;255:405–14. doi: 10.​1097/​SLA.​0b013e31824856f5​. CrossRefPubMed
55.
Zurück zum Zitat Alvarez FA, Ardiles V, Sanchez Claria R, Pekolj J, de Santibañes E. Associating liver partition and portal vein ligation for staged hepatectomy (ALPPS): tips and tricks. J Gastrointest Surg. 2013;17:814–21. doi: 10.​1007/​s11605-012-2092-2. CrossRefPubMed Alvarez FA, Ardiles V, Sanchez Claria R, Pekolj J, de Santibañes E. Associating liver partition and portal vein ligation for staged hepatectomy (ALPPS): tips and tricks. J Gastrointest Surg. 2013;17:814–21. doi: 10.​1007/​s11605-012-2092-2. CrossRefPubMed
59.
Zurück zum Zitat Wilms C, Mueller L, Lenk C, Wittkugel O, Helmke K, Krupski-Berdien G, Rogiers X, Broering DC. Comparative study of portal vein embolization versus portal vein ligation for induction of hypertrophy of the future liver remnant using a mini-pig model. Ann Surg. 2008;247:825–34. doi: 10.​1097/​SLA.​0b013e31816a9d7c​. CrossRefPubMed Wilms C, Mueller L, Lenk C, Wittkugel O, Helmke K, Krupski-Berdien G, Rogiers X, Broering DC. Comparative study of portal vein embolization versus portal vein ligation for induction of hypertrophy of the future liver remnant using a mini-pig model. Ann Surg. 2008;247:825–34. doi: 10.​1097/​SLA.​0b013e31816a9d7c​. CrossRefPubMed
60.
Zurück zum Zitat Rohatgi S, Harrison EM, Powell JJ, Wigmore SJ. ALPPS: adverse outcomes demand clear justification in an era of improving survival for colorectal liver metastases. World J Surg. 2014. doi: 10.​1007/​s00268-014-2726-5. Rohatgi S, Harrison EM, Powell JJ, Wigmore SJ. ALPPS: adverse outcomes demand clear justification in an era of improving survival for colorectal liver metastases. World J Surg. 2014. doi: 10.​1007/​s00268-014-2726-5.
62.
Zurück zum Zitat Schadde E, Ardiles V, Robles-Campos R, Malago M, Machado M, Hernandez-Alejandro R, Soubrane O, Schnitzbauer AA, Raptis D, Tschuor C, Petrowsky H, De Santibanes E, Clavien P-A. Early survival and safety of ALPPS: first report of the international ALPPS registry. Ann Surg. 2014;260:829–38. doi: 10.​1097/​SLA.​0000000000000947​. CrossRefPubMed Schadde E, Ardiles V, Robles-Campos R, Malago M, Machado M, Hernandez-Alejandro R, Soubrane O, Schnitzbauer AA, Raptis D, Tschuor C, Petrowsky H, De Santibanes E, Clavien P-A. Early survival and safety of ALPPS: first report of the international ALPPS registry. Ann Surg. 2014;260:829–38. doi: 10.​1097/​SLA.​0000000000000947​. CrossRefPubMed
63.
Zurück zum Zitat Schadde E, Schnitzbauer AA, Tschuor C, Raptis DA, Bechstein WO, Clavien P-A. Systematic review and meta-analysis of feasibility, safety, and efficacy of a novel procedure: associating liver partition and portal vein ligation for staged hepatectomy. Ann Surg Oncol. 2014. doi: 10.​1245/​s10434-014-4213-5. Schadde E, Schnitzbauer AA, Tschuor C, Raptis DA, Bechstein WO, Clavien P-A. Systematic review and meta-analysis of feasibility, safety, and efficacy of a novel procedure: associating liver partition and portal vein ligation for staged hepatectomy. Ann Surg Oncol. 2014. doi: 10.​1245/​s10434-014-4213-5.
64.
Zurück zum Zitat Shindoh J, Vauthey J-N, Zimmitti G, Curley SA, Huang SY, Mahvash A, Gupta S, Wallace MJ, Aloia TA. Analysis of the efficacy of portal vein embolization for patients with extensive liver malignancy and very low future liver remnant volume, including a comparison with the associating liver partition with portal vein ligation for staged hepatectomy approa. J Am Coll Surg. 2013;217:126–34. doi: 10.​1016/​j.​jamcollsurg.​2013.​03.​004. CrossRefPubMed Shindoh J, Vauthey J-N, Zimmitti G, Curley SA, Huang SY, Mahvash A, Gupta S, Wallace MJ, Aloia TA. Analysis of the efficacy of portal vein embolization for patients with extensive liver malignancy and very low future liver remnant volume, including a comparison with the associating liver partition with portal vein ligation for staged hepatectomy approa. J Am Coll Surg. 2013;217:126–34. doi: 10.​1016/​j.​jamcollsurg.​2013.​03.​004. CrossRefPubMed
65.
Zurück zum Zitat Schadde E, Ardiles V, Slankamenac K, Tschuor C, Sergeant G, Amacker N, Baumgart J, Croome K, Hernandez-Alejandro R, Lang H, de Santibaňes E, Clavien P-A. ALPPS offers a better chance of complete resection in patients with primarily unresectable liver tumors compared with conventional-staged hepatectomies: results of a multicenter analysis. World J Surg. 2014;38:1510–9. doi: 10.​1007/​s00268-014-2513-3. CrossRefPubMed Schadde E, Ardiles V, Slankamenac K, Tschuor C, Sergeant G, Amacker N, Baumgart J, Croome K, Hernandez-Alejandro R, Lang H, de Santibaňes E, Clavien P-A. ALPPS offers a better chance of complete resection in patients with primarily unresectable liver tumors compared with conventional-staged hepatectomies: results of a multicenter analysis. World J Surg. 2014;38:1510–9. doi: 10.​1007/​s00268-014-2513-3. CrossRefPubMed
66.
Zurück zum Zitat Ratti F, Schadde E, Masetti M, Massani M, Zanello M, Serenari M, Cipriani F, Bonariol L, Bassi N, Aldrighetti L, Jovine E. Strategies to increase the resectability of patients with colorectal liver metastases: a multi-center case-match analysis of alpps and conventional two-stage hepatectomy. Ann Surg Oncol. 2015. doi: 10.​1245/​s10434-014-4291-4. Ratti F, Schadde E, Masetti M, Massani M, Zanello M, Serenari M, Cipriani F, Bonariol L, Bassi N, Aldrighetti L, Jovine E. Strategies to increase the resectability of patients with colorectal liver metastases: a multi-center case-match analysis of alpps and conventional two-stage hepatectomy. Ann Surg Oncol. 2015. doi: 10.​1245/​s10434-014-4291-4.
67.
Zurück zum Zitat Broering DC, Hillert C, Krupski G, Fischer L, Mueller L, Achilles EG, Schulte am Esch J, Rogiers X. Portal vein embolization vs. portal vein ligation for induction of hypertrophy of the future liver remnant. J Gastrointest Surg 2002;6:905–13. CrossRefPubMed Broering DC, Hillert C, Krupski G, Fischer L, Mueller L, Achilles EG, Schulte am Esch J, Rogiers X. Portal vein embolization vs. portal vein ligation for induction of hypertrophy of the future liver remnant. J Gastrointest Surg 2002;6:905–13. CrossRefPubMed
70.
Zurück zum Zitat Fujii H, Hirose T, Oe S, Yasuchika K, Azuma H, Fujikawa T, Nagao M, Yamaoka Y. Contribution of bone marrow cells to liver regeneration after partial hepatectomy in mice. J Hepatol. 2002;36:653–9. CrossRefPubMed Fujii H, Hirose T, Oe S, Yasuchika K, Azuma H, Fujikawa T, Nagao M, Yamaoka Y. Contribution of bone marrow cells to liver regeneration after partial hepatectomy in mice. J Hepatol. 2002;36:653–9. CrossRefPubMed
71.
Zurück zum Zitat Zhan Y-T, Wang Y, Wei L, Liu B, Chen H-S, Cong X, Fei R. Differentiation of rat bone marrow stem cells in liver after partial hepatectomy. World J Gastroenterol. 2006;12:5051–4. CrossRefPubMedPubMedCentral Zhan Y-T, Wang Y, Wei L, Liu B, Chen H-S, Cong X, Fei R. Differentiation of rat bone marrow stem cells in liver after partial hepatectomy. World J Gastroenterol. 2006;12:5051–4. CrossRefPubMedPubMedCentral
72.
Zurück zum Zitat Fiegel HC, Lange C, Kneser U, Lambrecht W, Zander AR, Rogiers X, Kluth D. Fetal and adult liver stem cells for liver regeneration and tissue engineering. J Cell Mol Med. 2006;10:577–87. CrossRefPubMed Fiegel HC, Lange C, Kneser U, Lambrecht W, Zander AR, Rogiers X, Kluth D. Fetal and adult liver stem cells for liver regeneration and tissue engineering. J Cell Mol Med. 2006;10:577–87. CrossRefPubMed
73.
Zurück zum Zitat Okumoto K, Saito T, Haga H, Hattori E, Ishii R, Karasawa T, Suzuki A, Misawa K, Sanjo M, Ito J, Sugahara K, Saito K, Togashi H, Kawata S. Characteristics of rat bone marrow cells differentiated into a liver cell lineage and dynamics of the transplanted cells in the injured liver. J Gastroenterol. 2006;41:62–9. doi: 10.​1007/​s00535-005-1723-8. CrossRefPubMed Okumoto K, Saito T, Haga H, Hattori E, Ishii R, Karasawa T, Suzuki A, Misawa K, Sanjo M, Ito J, Sugahara K, Saito K, Togashi H, Kawata S. Characteristics of rat bone marrow cells differentiated into a liver cell lineage and dynamics of the transplanted cells in the injured liver. J Gastroenterol. 2006;41:62–9. doi: 10.​1007/​s00535-005-1723-8. CrossRefPubMed
74.
Zurück zum Zitat Brulport M, Schormann W, Bauer A, Hermes M, Elsner C, Hammersen FJ, Beerheide W, Spitkovsky D, Härtig W, Nussler A, Horn LC, Edelmann J, Pelz-Ackermann O, Petersen J, Kamprad M, von Mach M, Lupp A, Zulewski H, Hengstler JG. Fate of extrahepatic human stem and precursor cells after transplantation into mouse livers. Hepatology. 2007;46:861–70. doi: 10.​1002/​hep.​21745. CrossRefPubMed Brulport M, Schormann W, Bauer A, Hermes M, Elsner C, Hammersen FJ, Beerheide W, Spitkovsky D, Härtig W, Nussler A, Horn LC, Edelmann J, Pelz-Ackermann O, Petersen J, Kamprad M, von Mach M, Lupp A, Zulewski H, Hengstler JG. Fate of extrahepatic human stem and precursor cells after transplantation into mouse livers. Hepatology. 2007;46:861–70. doi: 10.​1002/​hep.​21745. CrossRefPubMed
78.
Zurück zum Zitat am Esch JS, Knoefel WT, Klein M, Ghodsizad A, Fuerst G, Poll LW, Piechaczek C, Burchardt ER, Feifel N, Stoldt V, Stockschläder M, Stoecklein N, Tustas RY, Eisenberger CF, Peiper M, Häussinger D, Hosch SB. Portal application of autologous CD133 + bone marrow cells to the liver: a novel concept to support hepatic regeneration. Stem Cells. 2005;23:463–70. doi: 10.​1634/​stemcells.​2004-0283. CrossRefPubMed am Esch JS, Knoefel WT, Klein M, Ghodsizad A, Fuerst G, Poll LW, Piechaczek C, Burchardt ER, Feifel N, Stoldt V, Stockschläder M, Stoecklein N, Tustas RY, Eisenberger CF, Peiper M, Häussinger D, Hosch SB. Portal application of autologous CD133 + bone marrow cells to the liver: a novel concept to support hepatic regeneration. Stem Cells. 2005;23:463–70. doi: 10.​1634/​stemcells.​2004-0283. CrossRefPubMed
79.
Zurück zum Zitat Fürst G, Schulte am Esch J, Poll LW, Hosch SB, Fritz LB, Klein M, Godehardt E, Krieg A, Wecker B, Stoldt V, Stockschläder M, Eisenberger CF, Mödder U, Knoefel WT. Portal vein embolization and autologous CD133 + bone marrow stem cells for liver regeneration: initial experience. Radiology 2007;243:171–9. doi: 10.​1148/​radiol.​2431060625. CrossRefPubMed Fürst G, Schulte am Esch J, Poll LW, Hosch SB, Fritz LB, Klein M, Godehardt E, Krieg A, Wecker B, Stoldt V, Stockschläder M, Eisenberger CF, Mödder U, Knoefel WT. Portal vein embolization and autologous CD133 + bone marrow stem cells for liver regeneration: initial experience. Radiology 2007;243:171–9. doi: 10.​1148/​radiol.​2431060625. CrossRefPubMed
80.
Zurück zum Zitat am Esch JS, Schmelzle M, Fürst G, Robson SC, Krieg A, Duhme C, Tustas RY, Alexander A, Klein HM, Topp SA, Bode JG, Häussinger D, Eisenberger CF, Knoefel WT. Infusion of CD133 + bone marrow-derived stem cells after selective portal vein embolization enhances functional hepatic reserves after extended right hepatectomy: a retrospective single-center study. Ann Surg. 2012;255:79–85. doi: 10.​1097/​SLA.​0b013e31823d7d08​. CrossRefPubMed am Esch JS, Schmelzle M, Fürst G, Robson SC, Krieg A, Duhme C, Tustas RY, Alexander A, Klein HM, Topp SA, Bode JG, Häussinger D, Eisenberger CF, Knoefel WT. Infusion of CD133 + bone marrow-derived stem cells after selective portal vein embolization enhances functional hepatic reserves after extended right hepatectomy: a retrospective single-center study. Ann Surg. 2012;255:79–85. doi: 10.​1097/​SLA.​0b013e31823d7d08​. CrossRefPubMed
82.
Zurück zum Zitat Poon RT, Fan ST, Lo CM, Liu CL, Lam CM, Yuen WK, Yeung C, Wong J. Improving perioperative outcome expands the role of hepatectomy in management of benign and malignant hepatobiliary diseases: analysis of 1222 consecutive patients from a prospective database. Ann Surg. 2004;240:698–708 (discussion 708–10). PubMedPubMedCentral Poon RT, Fan ST, Lo CM, Liu CL, Lam CM, Yuen WK, Yeung C, Wong J. Improving perioperative outcome expands the role of hepatectomy in management of benign and malignant hepatobiliary diseases: analysis of 1222 consecutive patients from a prospective database. Ann Surg. 2004;240:698–708 (discussion 708–10). PubMedPubMedCentral
84.
Zurück zum Zitat Yamamoto J, Kosuge T, Takayama T, Shimada K, Yamasaki S, Ozaki H, Yamaguchi N, Mizuno S, Makuuchi M. Perioperative blood transfusion promotes recurrence of hepatocellular carcinoma after hepatectomy. Surgery. 1994;115:303–9. PubMed Yamamoto J, Kosuge T, Takayama T, Shimada K, Yamasaki S, Ozaki H, Yamaguchi N, Mizuno S, Makuuchi M. Perioperative blood transfusion promotes recurrence of hepatocellular carcinoma after hepatectomy. Surgery. 1994;115:303–9. PubMed
86.
Zurück zum Zitat Huguet C, Nordlinger B, Bloch P, Conard J. Tolerance of the human liver to prolonged normothermic ischemia. A biological study of 20 patients submitted to extensive hepatectomy. Arch Surg. 1978;113:1448–51. CrossRefPubMed Huguet C, Nordlinger B, Bloch P, Conard J. Tolerance of the human liver to prolonged normothermic ischemia. A biological study of 20 patients submitted to extensive hepatectomy. Arch Surg. 1978;113:1448–51. CrossRefPubMed
87.
Zurück zum Zitat Nakajima Y, Shimamura T, Kamiyama T, Matsushita M, Sato N, Todo S. Control of intraoperative bleeding during liver resection: analysis of a questionnaire sent to 231 Japanese hospitals. Surg Today. 2002;32:48–52. CrossRefPubMed Nakajima Y, Shimamura T, Kamiyama T, Matsushita M, Sato N, Todo S. Control of intraoperative bleeding during liver resection: analysis of a questionnaire sent to 231 Japanese hospitals. Surg Today. 2002;32:48–52. CrossRefPubMed
88.
Zurück zum Zitat Van der Bilt JDW, Livestro DP, Borren A, van Hillegersberg R, Borel Rinkes IHM. European survey on the application of vascular clamping in liver surgery. Dig Surg. 2007;24:423–35. doi: 10.​1159/​000108325. CrossRefPubMed Van der Bilt JDW, Livestro DP, Borren A, van Hillegersberg R, Borel Rinkes IHM. European survey on the application of vascular clamping in liver surgery. Dig Surg. 2007;24:423–35. doi: 10.​1159/​000108325. CrossRefPubMed
89.
90.
Zurück zum Zitat Gurusamy KS, Kumar Y, Pamecha V, Sharma D, Davidson BR. Ischaemic pre-conditioning for elective liver resections performed under vascular occlusion. Cochrane database Syst Rev 2009;CD007629. doi: 10.​1002/​14651858.​CD007629. Gurusamy KS, Kumar Y, Pamecha V, Sharma D, Davidson BR. Ischaemic pre-conditioning for elective liver resections performed under vascular occlusion. Cochrane database Syst Rev 2009;CD007629. doi: 10.​1002/​14651858.​CD007629.
91.
Zurück zum Zitat Esaki M, Sano T, Shimada K, Sakamoto Y, Takahashi Y, Wakai K, Kosuge T. Randomized clinical trial of hepatectomy using intermittent pedicle occlusion with ischaemic intervals of 15 versus 30 min. Br J Surg. 2006;93:944–51. doi: 10.​1002/​bjs.​5399. CrossRefPubMed Esaki M, Sano T, Shimada K, Sakamoto Y, Takahashi Y, Wakai K, Kosuge T. Randomized clinical trial of hepatectomy using intermittent pedicle occlusion with ischaemic intervals of 15 versus 30 min. Br J Surg. 2006;93:944–51. doi: 10.​1002/​bjs.​5399. CrossRefPubMed
92.
93.
Zurück zum Zitat Huguet C, Gavelli A, Chieco PA, Bona S, Harb J, Joseph JM, Jobard J, Gramaglia M, Lasserre M. Liver ischemia for hepatic resection: where is the limit? Surgery. 1992;111:251–9. PubMed Huguet C, Gavelli A, Chieco PA, Bona S, Harb J, Joseph JM, Jobard J, Gramaglia M, Lasserre M. Liver ischemia for hepatic resection: where is the limit? Surgery. 1992;111:251–9. PubMed
95.
Zurück zum Zitat Choukèr A, Schachtner T, Schauer R, Dugas M, Löhe F, Martignoni A, Pollwein B, Niklas M, Rau HG, Jauch KW, Peter K, Thiel M. Effects of Pringle manoeuvre and ischaemic preconditioning on haemodynamic stability in patients undergoing elective hepatectomy: a randomized trial. Br J Anaesth. 2004;93:204–11. doi: 10.​1093/​bja/​aeh195. CrossRefPubMed Choukèr A, Schachtner T, Schauer R, Dugas M, Löhe F, Martignoni A, Pollwein B, Niklas M, Rau HG, Jauch KW, Peter K, Thiel M. Effects of Pringle manoeuvre and ischaemic preconditioning on haemodynamic stability in patients undergoing elective hepatectomy: a randomized trial. Br J Anaesth. 2004;93:204–11. doi: 10.​1093/​bja/​aeh195. CrossRefPubMed
96.
Zurück zum Zitat Heizmann O, Meimarakis G, Volk A, Matz D, Oertli D, Schauer RJ. Ischemic preconditioning-induced hyperperfusion correlates with hepatoprotection after liver resection. World J Gastroenterol. 2010;16:1871–8. CrossRefPubMedPubMedCentral Heizmann O, Meimarakis G, Volk A, Matz D, Oertli D, Schauer RJ. Ischemic preconditioning-induced hyperperfusion correlates with hepatoprotection after liver resection. World J Gastroenterol. 2010;16:1871–8. CrossRefPubMedPubMedCentral
101.
Zurück zum Zitat Auphan N, DiDonato JA, Rosette C, Helmberg A, Karin M. Immunosuppression by glucocorticoids: inhibition of NF-kappa B activity through induction of I kappa B synthesis. Science. 1995;270:286–90. CrossRefPubMed Auphan N, DiDonato JA, Rosette C, Helmberg A, Karin M. Immunosuppression by glucocorticoids: inhibition of NF-kappa B activity through induction of I kappa B synthesis. Science. 1995;270:286–90. CrossRefPubMed
103.
Zurück zum Zitat Barber AE, Coyle SM, Fischer E, Smith C, van der Poll T, Shires GT, Lowry SF. Influence of hypercortisolemia on soluble tumor necrosis factor receptor II and interleukin-1 receptor antagonist responses to endotoxin in human beings. Surgery. 1995;118:406–11. CrossRefPubMed Barber AE, Coyle SM, Fischer E, Smith C, van der Poll T, Shires GT, Lowry SF. Influence of hypercortisolemia on soluble tumor necrosis factor receptor II and interleukin-1 receptor antagonist responses to endotoxin in human beings. Surgery. 1995;118:406–11. CrossRefPubMed
105.
Zurück zum Zitat Figueroa I, Santiago-Delpín EA. Steroid protection of the liver during experimental eschemia. Surg Gynecol Obstet. 1975;140:368–70. PubMed Figueroa I, Santiago-Delpín EA. Steroid protection of the liver during experimental eschemia. Surg Gynecol Obstet. 1975;140:368–70. PubMed
107.
Zurück zum Zitat Orci LA, Toso C, Mentha G, Morel P, Majno PE. Systematic review and meta-analysis of the effect of perioperative steroids on ischaemia-reperfusion injury and surgical stress response in patients undergoing liver resection. Br J Surg. 2013;100:600–9. doi: 10.​1002/​bjs.​9035. CrossRefPubMed Orci LA, Toso C, Mentha G, Morel P, Majno PE. Systematic review and meta-analysis of the effect of perioperative steroids on ischaemia-reperfusion injury and surgical stress response in patients undergoing liver resection. Br J Surg. 2013;100:600–9. doi: 10.​1002/​bjs.​9035. CrossRefPubMed
Metadaten
Titel
Current strategies for preoperative conditioning of the liver to expand criteria for resectability of hepatic metastases
verfasst von
H. M. Hau
H. -M. Tautenhahn
M. Schmelzle
H. M. Morgul
M. Moche
M. Bartels
FACS Prof. Dr. med. D. Uhlmann
Publikationsdatum
01.08.2016
Verlag
Springer Vienna
Erschienen in
European Surgery / Ausgabe 4/2016
Print ISSN: 1682-8631
Elektronische ISSN: 1682-4016
DOI
https://doi.org/10.1007/s10353-015-0381-1